VYCO
Vycor Medical Inc
$0.06
+0.00 (+0.00%)
At close · Jul 8
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions, among others, raise substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$2.10M
Shares
33,372,796
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.86M
+17.2%
FY2025
Net Income
-$72.43K
+32.4%
FY2025
Gross Margin
83.78%
-5.7pp
FY2025
Operating Margin
1.82%
+2.4pp
FY2025
Diluted EPS
-$0.01
0%
FY2025
Operating Cash Flow
-$13.47K
-122.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.89M | $1.86M | $1.59M | $1.46M | $1.22M | $1.39M | $1.14M | $1.39M | $1.51M | $1.38M | $1.45M | $1.14M | $1.25M | $1.09M | $1.21M | $971.37K | — | |
| $307.84K | $302.29K | $166.81K | $144.95K | $140.64K | $134.73K | $132.46K | $134.77K | $169.6K | $227.13K | $184.69K | $164.12K | $156.3K | $153.83K | $179.53K | $176.26K | $48.74K | |
| $1.58M | $1.56M | $1.42M | $1.32M | $1.08M | $1.26M | $1.01M | $1.26M | $1.34M | $1.16M | $1.27M | $974.52K | $1.09M | $935.54K | $1.03M | $795.11K | $267.71K | |
| — | 83.78% | 89.5% | 90.08% | 88.5% | 90.33% | 88.4% | 90.32% | 88.76% | 83.6% | 87.29% | 85.59% | 87.5% | 85.88% | 85.1% | 81.85% | — | |
| — | $9963 | $15.33K | $22.56K | — | $15.16K | $0 | $0 | — | $3015 | $4739 | $71.51K | $69.11K | $53.45K | $126.04K | $115.67K | $15.21K | |
| — | — | — | — | — | — | — | — | $2.18M | $2.19M | $2.6M | $2.53M | $3.39M | $2.81M | $3.41M | $4.99M | $1.92M | |
| $1.42M | $1.46M | $1.36M | $1.2M | $1.33M | $1.61M | $1.68M | $1.8M | $2.18M | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | $11.35K | $11.98K | $12.16K | $50.33K | $162.08K | $89.16K | $99.29K | $128.38K | $127.32K | $104.34K | $69.02K | -$21.54K | |
| $58.62K | $59.52K | $59.52K | $57.5K | $58.23K | $66.07K | $56.53K | $59.88K | $166.39K | $275.42K | $257.58K | $360.33K | $368.61K | $350.53K | $328.89K | $209.97K | $56.8K | |
| $1.49M | $1.53M | $1.43M | $1.28M | $1.39M | $1.69M | $1.74M | $1.86M | $2.66M | $2.47M | $2.86M | $2.97M | $3.83M | $3.22M | $3.82M | $5.42M | $2.2M | |
| $92.51K | $33.9K | -$9145 | $40.19K | -$306.51K | -$435.95K | -$727.39K | -$601.39K | -$1.32M | -$1.31M | -$1.59M | -$1.99M | -$2.73M | -$2.28M | -$2.79M | -$4.63M | -$1.94M | |
| — | 1.82% | -0.58% | 2.75% | -25.06% | -31.3% | -63.69% | -43.18% | -87.31% | -94.77% | -109.55% | -174.86% | -218.52% | -209.43% | -231.82% | -476.41% | — | |
| $151.14K | $93.42K | $50.38K | $97.69K | -$248.28K | -$369.88K | -$670.87K | -$541.52K | -$1.15M | -$1.04M | -$1.33M | -$1.63M | -$2.36M | -$1.93M | -$2.47M | -$4.42M | -$1.88M | |
| — | $12K | $12K | $12K | $12K | $12K | $13.2K | $13.2K | — | — | — | — | — | — | $137.93K | $127.14K | $45.88K | |
| -$104.1K | -$104.09K | -$97.81K | -$103.27K | -$93.19K | $27.71K | -$72.92K | -$68.79K | -$61.62K | -$164.48K | -$60.9K | -$91.63K | -$1.32M | -$163.02K | -$137.21K | -$150.86K | -$45.87K | |
| -$11.58K | -$70.19K | -$106.95K | -$63.08K | -$399.71K | -$408.25K | -$800.31K | -$670.19K | $1.38M | $1.48M | -$1.65M | -$2.08M | -$4.05M | -$2.44M | -$2.93M | -$4.78M | -$1.98M | |
| — | — | — | — | — | — | — | — | — | — | — | $0 | $0 | — | — | — | $2248 | |
| -$13.76K | -$72.43K | -$107.2K | -$69.69K | -$404.92K | -$435.66K | -$822.48K | -$796.2K | -$1.38M | -$1.48M | -$1.65M | -$2.08M | -$4.05M | -$2.44M | -$2.93M | -$4.78M | -$1.98M | |
| — | -3.89% | -6.75% | -4.77% | -33.11% | -31.28% | -72.02% | -57.16% | -91.39% | -106.65% | -113.74% | -182.91% | -323.9% | -224.39% | -243.21% | -491.94% | — | |
| -$338.13K | -$396.8K | -$431.57K | -$394.06K | -$729.29K | -$760.03K | -$1.15M | -$1.12M | -$1.7M | -$1.8M | -$1.83M | -$2.25M | -$4.05M | — | — | — | — | |
| -$13.76K | -$72.43K | -$107.2K | -$69.69K | -$404.92K | -$435.66K | -$822.48K | -$796.2K | — | -$1.47M | -$1.65M | -$2.15M | -$4.16M | -$2.41M | -$2.93M | — | — | |
| USD/shares | — | -$0.01 | -$0.01 | -$0.01 | -$0.02 | -$0.03 | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$0.01 | -$0.01 | -$0.01 | -$0.02 | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 33.37M | 32.88M | 32.6M | 31.71M | 29.63M | 26.1M | 23.96M | 21.6M | 18.37M | 11.07M | 10.84M | 10.27M | 6.32M | 5.64M | 5.2M | — |
| shares | — | 33.37M | 32.88M | 32.6M | 31.71M | 29.63M | 26.1M | 23.96M | 21.6M | 18.37M | 11.07M | 10.84M | 10.27M | 6.32M | 5.64M | 5.2M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Vycor Medical Inc | $1,796,070 | $1,515,744 | — | — | — | — |
| Nova Vision Inc | $67,330 | $73,580 | — | — | — | — |
| NovaVision | — | — | $82,006 | $92,074 | $119,385 | $102,483 |
| Vycor Medical | — | — | $1,378,598 | $1,130,915 | $1,273,602 | $1,039,562 |
By Geography (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| United States | $1,858,494 | $1,585,644 | $1,453,895 | $1,214,723 | $1,374,770 | $1,125,226 |
| Europe | $4,906 | $3,680 | $6,709 | $8,266 | $18,217 | $16,819 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Vycor Medical Inc | $493,787 | $353,052 | — | — |
| Nova Vision Inc | -$183,878 | -$177,917 | — | — |
| Corporate | -$276,009 | -$184,280 | -$151,846 | -$322,490 |
| NovaVision | — | — | -$191,810 | -$223,351 |
| Vycor Medical | — | — | $383,847 | $239,327 |
Operating Margin by Segment (%)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Vycor Medical Inc | 27.5% | 23.3% | — | — |
| Nova Vision Inc | -273.1% | -241.8% | — | — |
| NovaVision | — | — | -233.9% | -242.6% |
| Vycor Medical | — | — | 27.8% | 21.2% |